Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria

BMC Clinical Pharmacology

Volumn 9, Issue , 2009, Pages

  Oshikoya, Kazeem A ^a,b   Awobusuyi, Jacob O ^a  

^a LAGOS STATE UNIVERSITY   (Nigeria)

^b LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; COTRIMOXAZOLE; DICLOFENAC; ENALAPRIL; FANSIDAR; FUROSEMIDE; HEPARIN; ISOSORBIDE DINITRATE; ROXITHROMYCIN;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; DEMOGRAPHY; DENTIST; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART PALPITATION; HICCUP; HUMAN; JAUNDICE; MALE; MEDICAL EDUCATION; NIGERIA; NURSE; PHARMACIST; PHYSICIAN ATTITUDE; PHYSIOTHERAPIST; PROFESSIONAL COMPETENCE; QUESTIONNAIRE; TEACHING HOSPITAL; THROMBOCYTOPENIA; CROSS-SECTIONAL STUDY; HEALTH PERSONNEL ATTITUDE; MEDICAL STAFF; PHYSICIAN; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; EDUCATION, MEDICAL, CONTINUING; FEMALE; GUIDELINE ADHERENCE; HOSPITALS, TEACHING; HUMANS; MALE; MEDICAL STAFF, HOSPITAL; NIGERIA; PHYSICIANS; QUESTIONNAIRES;

EID: 69549105963     PISSN: None     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-9-14     Document Type: Article

References (44)

1. Lazarou J Pomeranz BH Corey PN Incidence of adverse reactions in hospitalized patients. A meta-analysis of prospective studies JAMA 1998, 279:1200-1205 10.1001/jama.279.15.1200 9555760
2. Pirmohamed M James S Meakin S Green C Scott AK et al Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients Br Med J 2004, 329:15-19 10.1136/bmj.329.7456.15
3. Oshikoya KA Adverse drug reaction in children: Types, incidence and risk factors Nig J Paediatr 2006, 33:29-35
4. Martinez-Mir I Garcia-Lopez M Palop V Ferrer JM Rubio E Morales-Olivas FJ A prospective study of adverse drug reactions in hospitalized children Br J Clin Pharmacol 1999, 47:681-688 10.1046/ j.1365-2125.1999.00943.x 2014265 10383547
5. Ayani I Aguirre C Gutierrez G Madariaga A Rodríguez-Sasiaín JM Martínez-Bengoechea MJ A cost analysis of suspected adverse drug reactions in a hospital emergency ward Pharmacoepidemiol Drug Saf 1999, 8:529-534 10.1002/ (SICI)1099-1557(199912)8:7<529::AID-PDS460>3.0.CO;2-J 15073897
6. Wu WK Pantaleo N Evaluation of outpatient adverse drug reactions leading to hospitalization Am J Health Syst Pharm 2003, 60:253-259 12613234
7. Edwards I Olsson S WHO: Global monitoring Pharmacovigilance Chichester: John Wiley & Sons Mann RD, Andrew E 2002:169-182
8. Ahmad SR Adverse drug event monitoring at the Food and Drug Administration J Gen Intern Med 2003, 285:437-443
9. Wysowsky DK Swartz L Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: The importance of reporting suspected reactions Arch Intern Med 2005, 165:1363-1369 10.1001/ archinte.165.12.1363 15983284
10. Lexchin J Is there a role for spontaneous reporting of adverse drug reactions? CMAJ 2006, 174:191-192 1329459 16415466
11. Lopez-Gonzalez E Herdeiro MT Figueiras A Determinants of under-reporting of adverse drug reactions: A systematic review Drug Saf 2009, 32:19-31 10.2165/00002018-200932010-00002 19132802
12. Smith CC Bennett PM Pearce HM Harrison PI Reynolds DJM Aronson JK Grahame-Smith DG Adverse drug reaction in a hospital general medical unit meriting notification to the Committee on Safety of Medicines Br J Clin Pharmacol 1996, 42:423-429 10.1111/j.1365-2125.1996.tb00004.x 2042689 8904613
13. Feely J Moriarty S O'Connor P Stimulating reporting of adverse drug reaction by using a fee Br Med J 1990, 300:22-23 10.1136/bmj.300.6716.22
14. Inman WH Attitudes to adverse drug-reaction reporting Br J Clin Pharmacol 1996, 41:433-435 8735689
15. Robins AH Weir M Biersteker EM Attitudes to adverse drug reactions and their reporting among medical practitioners S Afr Med J 1987, 72:131-134 3616786
16. Ball D Tisocki T Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare: A pilot study Cent Afr J Med 1998, 44:190-195 10101417
17. Enwere OO Fawole OI Adverse drug reactions reporting by physicians in Ibadan, Nigeria Pharmacoepidemiol Drug Saf 2008, 17:517-522 10.1002/ pds.1597 18404621
18. Belton KJ Lewis SC Payne S Rawlins MD Wood S Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom Br J Cin Pharmacol 1995, 39:223-226
19. Bateman DN Sanders GL Rawlins MD Attitudes to adverse drug reaction reporting in the Northern Region Br J Clin Pharmacol 1992, 34:421-426 1381471 1467137
20. Belton K The European Pharmacovigilance Research Group Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union Eur J Clin Pharmacol 1997, 52:423-427 10.1007/ s002280050314 9342576
21. Green CF Mottram DR Rowe PH Pirmohamed M Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting Br J Clin Pharmacol 2001, 51:81-86 10.1046/j.1365-2125.2001.01306.x 2014418 11167664
22. McGettigan P Golden J Conroy RM Arthur N Feely J Reporting of adverse drug reactions by hospital doctors and the response to intervention Br J Clin Pharmacol 1997, 44:98-100 10.1046/j.1365-2125.1997.00616.x 2042798 9241104
23. Herdeiro MT Figueiras A Polonia J Gestal-Otero JJ Physicians' attitudes and adverse drug reaction reporting: A case-control study in Portugal Drug Saf 2005, 28:825-833 10.2165/00002018-200528090-00007 16119975
24. Pouget-Zago P Lapeyre-Mestre M Bagheri H Montastruc JL Pharmacovigilance seen by a selected group of general practitioners and of residents in the Midi-Pyrénées Therapie 1995, 50:459-462 8571286
25. Milstein JB Faich GA Hsu JP et al Factors affecting physician reporting of adverse drug reactions Drug Inf J 1986, 20:157-164
26. Rogers AS Isreal E Smith CR Levine D McBean AM Valente C Faich G Physician knowledge, attitudes, and behaviour related to reporting adverse drug events Arch Intern Med 1988, 148:1596-1600 10.1001/ archinte.148.7.1596 3382304
27. Rehan HS Vasudev K Tripathi CD Adverse drug reaction monitoring: knowledge, attitude and practices of medical students and prescribers Nat Med J India 2002, 15:24-26
28. Li Q Zhang SM Chen HT Fang SP Yu X Liu D Shi LY Zeng FD Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions Chin Med J 2004, 117:856-861 15198887
29. van Grootheest AC van Puijenbroek EP de Jong-van den Berg LT Contribution of pharmacists to the reporting of adverse drug reactions Pharmacoepidemiol Drug Saf 2002, 11:205-210 10.1002/pds.702 12051119
30. Morrison-Griffiths S Walley TJ Park BK Breckenridge AM Pirmohamed M Reporting of adverse drug reactions by nurses Lancet 2003, 361:1347-1348 10.1016/S0140-6736(03)13043-7 12711472
31. Blenkinsopp A Wilkie P Wang M Patient reporting of suspected adverse drug reactions: A review of published literature and international experience Br J Clin Pharmacol 2006, 63:148-56 10.1111/ j.1365-2125.2006.02746.x
32. National Pharmacovigilance Centre (NPC), NAFDAC, Nigeria. Safety of medicines in Nigeria: A guide for detecting and reporting adverse drug reactions. NAFDAC-NPC-NIG-2004-1 Lagos: National Agency for Food and Drug Administration and Control 2004
33. Eland A Belton KJ van Grootheest AC Meiners AP Rawlins MD Stricker BH Attitudinal survey of voluntary reporting of adverse drug reactions Br J Clin Pharmcol 1999, 48:623-627 10.1046/j.1365-2125.1999.00060.x
34. Serrano Cozar G Esteban Calvo C Gijon Porta JA Vaquero Turiño I Vázquez Burgos MI Ibáñez Ruiz C Frías Iniesta J Adverse drug reactions and a program of voluntary notification: An opinion survey of primary care physicians Aten Primaria 1997, 19:307-312 9264670
35. Chatterjee S Lyle N Ghosh S A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India Drug Saf 2006, 29:641-642 10.2165/00002018-200629070-00009 16808556
36. Sott HD Thacher-Renshaw A Rosenbaun SE Waters WJ Jr Green M Andrews LJ Faich GA Physician reporting of adverse drug reactions: Results of the Rhode Island Adverse drug reaction reporting project JAMA 1990, 263:1785-1788 10.1001/jama.263.13.1785 2313850
37. Lee KK Chan TY Raymond K et al Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong Ann Pharmacother 1994, 28:1400-1403 7696734
38. Castel JM Figueiras A Pedrós C Laporte JR Capellà D Stimulating adverse drug reaction reporting: Effect of a drug safety bulletin and of including yellow cards in prescription pads Drug Saf 2003, 26:1049-1055 10.2165/00002018-200326140-00005 14583065
39. Oshikoya KA Njokanma OF Chukwura HA Ojo IO Adverse drug reactions in Nigerian children Paediatr Perinat Drug Ther 2007, 8:81-8 10.1185/ 146300907X199858
40. Weiss J Krebs S Hoffmann C Werner U Neubert A Brune K Rasher W Survey of adverse drug reactions on paediatric ward. A strategy for early detailed detection Pediatrics 2002, 110:254-257 10.1542/peds.110.2.254 12165575
41. Fattahi F Pourpak Z Moin M Karemenejad A Khotaei GT Mamishi S Siadati A Tabatabaei P Adverse drug reactions in hospitalized children in a development of infectious disease J Clin Pharmacol 2005, 45:1313-1318 10.1177/0091270005281205 16239365
42. Impicciatore P Choonara I Clarkson A Provasi D Pandolfini C Bonati M Incidence of adverse drug reactions in paediatric in/out-patients: A systematic review and meta-analysis of prospective studies Br J Clin Pharmacol 2001, 52:77-83 10.1046/j.0306-5251.2001.01407.x 2014499 11453893
43. Figueiras A Herdeiro MT Polónia J Gestal-Otero JJ An educational intervention to improve physician reporting of adverse drug reactions: A cluster-randomized controlled trial JAMA 2006, 296:1086-1093 10.1001/ jama.296.9.1086 16954488
44. Vallano A Cereza G Pedros C Agusti A Danes I Aguilera C Arnau JM Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital Br J Clin Pharmacol 2005, 60:653-658 1884880 16305591